ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2015
SGLT2 Inhibitors for Type 2 Diabetes Mellitus Treatment.
Abstract read
In one paragraph
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Temporal Trends and Future Projections of P ulmonary Embolism and Top Contributing Causes of death in the United States, 1968-2040: insights from the CDC WONDER database.Journal of thrombosis and thrombolysis · 2026Article
- Glycemic Patterns Assessed by Continuous Glucose Monitoring in People with Type 2 Diabetes Treated with Insulin Glargine 100 U/mL in Primary Care: The GPDetect Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Article
- Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in India.BMC endocrine disorders · 2026Observational
- Therapeutic Potential of Flavonoids in Diabetes Mellitus Management: Molecular Insights and the Future Directions for Drug Design.Current drug discovery technologies · 2026Review
- Observational
- The real-world anti-inflammatory effect of SGLT2i in patients with chronic heart failure.Journal of medicine and life · 2025Article
- Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2.Current medicinal chemistry · 2024Review
- Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing's syndrome, acromegaly and neuroendocrine tumours.Frontiers in endocrinology · 2023Review
- Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India.Revista da Associacao Medica Brasileira (1992) · 2023Article
- Review
- Review
- Oral GLP1 Analog: Where Does the Tide Go?Clinical medicine insights. Endocrinology and diabetes · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Raymond A Plodkowskiis a former chief of endocrinology and was an endocrinologist at the VA Sierra Nevada Health Care System in Reno. Dr. Plodkowski, , and are endocrinologists in the Division of Endocrinology, and Dr. McGarvey is also the associate program director of the Endocrinology Fellowship, all at Scripps Clinic in San Diego. Dr. Nguyen is the medical director of Las Vegas Endocrinology and an adjunct associate professor of medicine at Touro University Nevada College of Osteopathic Medicine, both in Nevada, and a clinical associate professor of clinical education at Arizona College of Osteopathic Medicine in Glendale, California. and are medical students at Touro University Nevada College of Osteopathic Medicine. is a senior medical resident at Valley Hospital Medical Center/Touro University.
Megan E McGarveyis a former chief of endocrinology and was an endocrinologist at the VA Sierra Nevada Health Care System in Reno. Dr. Plodkowski, , and are endocrinologists in the Division of Endocrinology, and Dr. McGarvey is also the associate program director of the Endocrinology Fellowship, all at Scripps Clinic in San Diego. Dr. Nguyen is the medical director of Las Vegas Endocrinology and an adjunct associate professor of medicine at Touro University Nevada College of Osteopathic Medicine, both in Nevada, and a clinical associate professor of clinical education at Arizona College of Osteopathic Medicine in Glendale, California. and are medical students at Touro University Nevada College of Osteopathic Medicine. is a senior medical resident at Valley Hospital Medical Center/Touro University.
Heather M Huribalis a former chief of endocrinology and was an endocrinologist at the VA Sierra Nevada Health Care System in Reno. Dr. Plodkowski, , and are endocrinologists in the Division of Endocrinology, and Dr. McGarvey is also the associate program director of the Endocrinology Fellowship, all at Scripps Clinic in San Diego. Dr. Nguyen is the medical director of Las Vegas Endocrinology and an adjunct associate professor of medicine at Touro University Nevada College of Osteopathic Medicine, both in Nevada, and a clinical associate professor of clinical education at Arizona College of Osteopathic Medicine in Glendale, California. and are medical students at Touro University Nevada College of Osteopathic Medicine. is a senior medical resident at Valley Hospital Medical Center/Touro University.
Keith Reisinger-Kindleis a former chief of endocrinology and was an endocrinologist at the VA Sierra Nevada Health Care System in Reno. Dr. Plodkowski, , and are endocrinologists in the Division of Endocrinology, and Dr. McGarvey is also the associate program director of the Endocrinology Fellowship, all at Scripps Clinic in San Diego. Dr. Nguyen is the medical director of Las Vegas Endocrinology and an adjunct associate professor of medicine at Touro University Nevada College of Osteopathic Medicine, both in Nevada, and a clinical associate professor of clinical education at Arizona College of Osteopathic Medicine in Glendale, California. and are medical students at Touro University Nevada College of Osteopathic Medicine. is a senior medical resident at Valley Hospital Medical Center/Touro University.
Bradley Krameris a former chief of endocrinology and was an endocrinologist at the VA Sierra Nevada Health Care System in Reno. Dr. Plodkowski, , and are endocrinologists in the Division of Endocrinology, and Dr. McGarvey is also the associate program director of the Endocrinology Fellowship, all at Scripps Clinic in San Diego. Dr. Nguyen is the medical director of Las Vegas Endocrinology and an adjunct associate professor of medicine at Touro University Nevada College of Osteopathic Medicine, both in Nevada, and a clinical associate professor of clinical education at Arizona College of Osteopathic Medicine in Glendale, California. and are medical students at Touro University Nevada College of Osteopathic Medicine. is a senior medical resident at Valley Hospital Medical Center/Touro University.
Mordecai Solomonis a former chief of endocrinology and was an endocrinologist at the VA Sierra Nevada Health Care System in Reno. Dr. Plodkowski, , and are endocrinologists in the Division of Endocrinology, and Dr. McGarvey is also the associate program director of the Endocrinology Fellowship, all at Scripps Clinic in San Diego. Dr. Nguyen is the medical director of Las Vegas Endocrinology and an adjunct associate professor of medicine at Touro University Nevada College of Osteopathic Medicine, both in Nevada, and a clinical associate professor of clinical education at Arizona College of Osteopathic Medicine in Glendale, California. and are medical students at Touro University Nevada College of Osteopathic Medicine. is a senior medical resident at Valley Hospital Medical Center/Touro University.
Quang T Nguyenis a former chief of endocrinology and was an endocrinologist at the VA Sierra Nevada Health Care System in Reno. Dr. Plodkowski, , and are endocrinologists in the Division of Endocrinology, and Dr. McGarvey is also the associate program director of the Endocrinology Fellowship, all at Scripps Clinic in San Diego. Dr. Nguyen is the medical director of Las Vegas Endocrinology and an adjunct associate professor of medicine at Touro University Nevada College of Osteopathic Medicine, both in Nevada, and a clinical associate professor of clinical education at Arizona College of Osteopathic Medicine in Glendale, California. and are medical students at Touro University Nevada College of Osteopathic Medicine. is a senior medical resident at Valley Hospital Medical Center/Touro University.
Funding
No grant is acknowledged in the PubMed record.
Abstract
SGLT2 inhibitors are plausible second-line drugs that provide powerful additional A
Identifiers
PMID
30766102PMC
PMC6375399What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.